Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Gerber

Showing results (91-100 of 173) with videos related to

Pageof 18
Sort By:
Geburtshilfe Und Frauenheilkunde|October 11, 2021
AGO Algorithms for the Treatment of Breast Cancer: Update 2021Andreas Schneeweiss, Peter A Fasching, Tanja Fehm, et al.
Oncology Research and Treatment|August 17, 2018
Implementation of a Systematic Literature Search Strategy in a National Breast Cancer Guideline: The Relevance of Systemic Therapy in Lymph Node Recurrent DiseaseTanja N Stüber, Stephanie Stangl, Christian Jackisch, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2006
CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93)Gunter von Minckwitz, Erika Graf, Matthias Geberth, et al.
Annals of Surgical Oncology|October 10, 2014
Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapyBeyhan Ataseven, Bianca Lederer, Jens U Blohmer, et al.
Archives of Gynecology and Obstetrics|January 19, 2019
Oncoplastic breast-conserving surgery: More relevant than ever? Results of a survey among breast surgeonsJoerg Heil, Fabian Riedel, Christine Solbach, et al.
Breast Care (Basel, Switzerland)|September 2, 2014
Sorafenib in the Treatment of Early Breast Cancer: Results of the Neoadjuvant Phase II Study - SOFIASibylle Loibl, Dennis Rokitta, Bettina Conrad, et al.
Journal of the National Cancer Institute|April 10, 2008
Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio studyGunter von Minckwitz, Sherko Kümmel, Petra Vogel, et al.
Journal of the National Cancer Institute|April 10, 2008
Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trialGunter von Minckwitz, Sherko Kümmel, Petra Vogel, et al.
Annals of Surgical Oncology|September 20, 2006
Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trialSibylle Loibl, Gunter von Minckwitz, Günther Raab, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO studyBernd Gerber, Gunter von Minckwitz, Heinrich Stehle, et al.
Pageof 18

Showing results (91-100 of 173) with videos related to

Sort By:
Pageof 18
Geburtshilfe Und Frauenheilkunde|October 11, 2021
AGO Algorithms for the Treatment of Breast Cancer: Update 2021Andreas Schneeweiss, Peter A Fasching, Tanja Fehm, et al.
Oncology Research and Treatment|August 17, 2018
Implementation of a Systematic Literature Search Strategy in a National Breast Cancer Guideline: The Relevance of Systemic Therapy in Lymph Node Recurrent DiseaseTanja N Stüber, Stephanie Stangl, Christian Jackisch, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2006
CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93)Gunter von Minckwitz, Erika Graf, Matthias Geberth, et al.
Annals of Surgical Oncology|October 10, 2014
Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapyBeyhan Ataseven, Bianca Lederer, Jens U Blohmer, et al.
Archives of Gynecology and Obstetrics|January 19, 2019
Oncoplastic breast-conserving surgery: More relevant than ever? Results of a survey among breast surgeonsJoerg Heil, Fabian Riedel, Christine Solbach, et al.
Breast Care (Basel, Switzerland)|September 2, 2014
Sorafenib in the Treatment of Early Breast Cancer: Results of the Neoadjuvant Phase II Study - SOFIASibylle Loibl, Dennis Rokitta, Bettina Conrad, et al.
Journal of the National Cancer Institute|April 10, 2008
Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio studyGunter von Minckwitz, Sherko Kümmel, Petra Vogel, et al.
Journal of the National Cancer Institute|April 10, 2008
Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trialGunter von Minckwitz, Sherko Kümmel, Petra Vogel, et al.
Annals of Surgical Oncology|September 20, 2006
Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trialSibylle Loibl, Gunter von Minckwitz, Günther Raab, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO studyBernd Gerber, Gunter von Minckwitz, Heinrich Stehle, et al.
Pageof 18